Aller au contenu principal
Nom officiel d’étiquetage de l’UEEntrée 3259 du glossaire

BENZYL SALICYLATE

Cette fiche confirme une dénomination commune officielle d’ingrédient pour l’étiquetage des produits cosmétiques de l’UE. Elle ne confirme pas à elle seule que la substance est autorisée, non restreinte ou sûre.

Aperçu des preuves mondiales

L’identité résolue présente des preuves réglementaires correspondantes dans 5 des 13 jeux de données de marchés indexés : 4 fiches de pays et 1 fiches d’annexes de l’UE. Chaque résultat et chaque lacune de preuves sont énumérés ci-dessous.

5 marchés avec preuves
Marchés vérifiés
13
Marchés avec preuves
5
Lacunes de preuves
8
Identifiants résolus
2

Identité résolue de la substance

CAS:118-58-1
EC:204-262-9
Fiches de l’index des ingrédients :
BENZYL SALICYLATE
Fonctions cosmétiques : PERFUMING, UV ABSORBER

Benzyl salicylate

Note de restriction de l’inventaire : III/75

3 noms correspondants ou signalés
BENZYL SALICYLATEBenzyl salicylateBenzyl salicylate (CAS No. 118-58-1)

Preuves réglementaires dans les 13 marchés

Ouvrez chaque fiche correspondante pour connaître son champ d’application, sa concentration, ses conditions, ses avertissements et la version de la source officielle.

Balayez ou faites défiler horizontalement pour voir la couverture des jeux de données et les actions suivantes.

MarchéRésultatFichesJeu de donnéesSignification / action suivante
European Union
EU
Soumise à restrictions1Ouvrir la fiche 1
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
Examinez chaque fiche associée et ses conditions exactes.
Great Britain
GB
Restricted1Ouvrir la fiche 1
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
Examinez chaque fiche associée et ses conditions exactes.
Canada
CA
Aucune correspondance trouvée0
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
New Zealand
NZ
Restricted1Ouvrir la fiche 1
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
Examinez chaque fiche associée et ses conditions exactes.
ASEAN
ASEAN
Aucune correspondance trouvée0
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
Regional annex coverage does not replace member-state implementation dates, notifications or national deviations.
China
CN
Aucune correspondance trouvée0
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.
Japan
JP
Aucune correspondance trouvée0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
Aucune correspondance trouvée0
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
Korean source wording is canonical and other positive lists/notices may still apply to the formulation.
United States
US
Aucune correspondance trouvée0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
Aucune correspondance trouvée0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
Aucune correspondance trouvée0
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
India
IN
Restricted1Ouvrir la fiche 1
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
Examinez chaque fiche associée et ses conditions exactes.
Saudi Arabia
SA
Restricted1Ouvrir la fiche 1
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
Examinez chaque fiche associée et ses conditions exactes.
Aucune ligne de marché ne correspond à ce filtre.

Fiches de marché correspondantes et conditions

Preuves exactes des annexes II à VI

Benzyl salicylate

Restrictions : The presence of the substance must be indicated in the list of ingredients referred to in Article 19(1)g when its concentration exceeds: - 0.001% in leave-on products - 0.01% in rinse-off products

Identité et propriétés chimiques

Structure chimique 2D PubChem pour le CAS 118-58-1
CAS 118-58-1PubChem CID 8363

Benzyl Salicylate

Benzyl salicylate is a member of phenols and a benzoate ester. It is functionally related to a salicylic acid. — ChEBI

Nom IUPAC
benzyl 2-hydroxybenzoate
Formule moléculaire
C14H12O3
Masse moléculaire
228.24 g/mol
Masse exacte
228.078644241 Da
XLogP3
3,2
Surface polaire topologique
46,5 Ų
Donneurs de liaisons hydrogène
1
Accepteurs de liaisons hydrogène
3
Unités covalentes
1
Stéréocentres définis
0

Également connu sous le nom de

Benzyl o-hydroxybenzoateSalicylic Acid Benzyl EsterSalicylic acid, benzyl esterPhenylmethyl 2-hydroxybenzoateFEMA No. 2151Benzoic acid, 2-hydroxy-, phenylmethyl esterSalicylsaeurebenzylester2-Hydroxybenzoic acid phenylmethyl ester
16 autres noms signalés
Salicyclic acid, benzyl esterWAO5MNK9TUNSC-6647RefChem:5597204-262-9NSC 6647Salicylic acid-benzyl esterEINECS 204-262-9Salicyclic acid benzyl esterBRN 2115365Benzyl salicylate, 98%2-Hydroxybenzoic acid, phenylmethyl esterBENZYL SALICYLATE [FHFI]benzylsalicylateCAS-118-58-1CCRIS 4749
Identifiants de bases de données externes

Preuves issues de bases de données scientifiques complémentaires

NIH PubChem PUG-View
Correspondance exacte d’identifiant8363

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou Source: CAMEO Chemicals
  • Signal: Warning Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H317: May cause an allergic skin reaction [Warning Sensitization, Skin] Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, and P501 (click each P-code to see the statement) Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Note: This chemical does not meet GHS hazard criteria for 0.4% (9 of 2207) of reports. Source: European Chemicals Agency (ECHA)
  • Signal: Warning Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H317 (99%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (76.2%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H411 (24.1%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]; H412 (68.4%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264+P265, P272, P273, P280, P302+P352, P305+P351+P338, P321, P333+P317, P337+P317, P362+P364, P391, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 2207 reports by companies from 42 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 9 of 2207 reports by companies.; There are 41 notifications provided by 2198 of 2207 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Signal: Warning Source: NITE-CMC
  • GHS Hazard Statements: H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H320: Causes eye irritation [Warning Serious eye damage/eye irritation]; H361: Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H401: Toxic to aquatic life [Hazardous to the aquatic environment, acute hazard]; H411: Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Source: NITE-CMC
  • Precautionary Statement Codes: P203, P261, P264+P265, P272, P273, P280, P302+P352, P305+P351+P338, P318, P321, P333+P317, P337+P317, P362+P364, P391, P405, and P501 (click each P-code to see the statement) Source: NITE-CMC
  • Signal: Warning Source: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • NFPA Health Rating: 0 - Materials that, under emergency conditions, would offer no hazard beyond that of ordinary combustible materials. Source: Hazardous Substances Data Bank (HSDB)
  • NFPA Fire Rating: 1 - Materials that must be preheated before ignition can occur. Materials require considerable preheating, under all ambient temperature conditions, before ignition and combustion can occur. Source: Hazardous Substances Data Bank (HSDB)
  • NFPA Instability Rating: 0 - Materials that in themselves are normally stable, even under fire conditions. Source: Hazardous Substances Data Bank (HSDB)
  • Cosmetic Ingredient Review Conclusion: The CIR Expert Panel concluded that Benzyl Salicylate is safe in cosmetics in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA). Source: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Safe for use in cosmetics, with qualifications Source: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: IDENTIFICATION AND USE: Benzyl salicylate is a thick colorless liquid. Benzyl salicylate is widely used in soap and cosmetic industry as fragrance; also effective in absorbing UV light, and can be used in protective sunscreen lotions. Benzyl salicylate is also used in deodorant sprays. HUMAN STUDIES: Benzyl salicylate has a very low potential to induce hypersensitivity or to elicit reactions presumably attributable to pre-existing sensitization. Estrogenic potential of benzyl salicylate was tested using an in vitro human estrogen receptor alpha(hERalpha)-coactivator recruiting assay. Benzyl salicylate showed obvious in vitro hERalpha agonistic activities and exhibited a higher estrogenic activity compared to bisphenol A. Estrogenic activity was also demonstrated in assays using the estrogen-responsive MCF7 human breast cancer cell line. ANIMAL STUDIES: Benzyl salicylate was not irritating in the isolated bovine cornea test. Erythema was observed in the rabbit skin test. Estrogenic potential of benzyl salicylate was tested using an in vivo immature rodent uterotrophic bioassay. The uterine weights were significantly increased in mice treated with 11.1, 33.3, 100 and 300 mg/kg/day be Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Bioconcentration: An estimated BCF of 320 was calculated in fish for benzyl salicylate(SRC), using an estimated log Kow of 4.31(1) and a regression-derived equation(1). According to a classification scheme(2), this BCF suggests the potential for bioconcentration in aquatic organisms is high(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 3300(SRC), determined from a structure estimation method(2), indicates that benzyl salicylate is expected to have slight mobility in soil(SRC). Volatilization of benzyl salicylate from moist soil surfaces may be an important fate process(SRC) given an estimated Henry's Law constant of 2.7X10-6 atm-cu m/mole(SRC) derived from its vapor pressure, 7.8X10-5 mm Hg(3), and water solubility, 8.8 mg/L(3). However, adsorption to soil is expected to attenuate volatilization(SRC). Benzyl salicylate is not expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(3). Utilizing the Manometric Respirometry test, 93% of the Theoretical BOD was reached in 4 weeks indicating that biodegradation is an important environmental fate process in soil(3). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 3300(SRC), determined from a structure estimation method(2), indicates that benzyl salicylate is expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces may occur(3) based upon an estimated Henry's Law constant of 2.7X10-6 atm-cu m/mole(SRC) derived from its vapor pressure, 7.8X10-5 mm Hg(3), and water solubility, 8.8 mg/L(3). Using this Henry's Law constant and an estimation method(4), volatilization half-lives for a model river and model lake are 14 and 160 days, respectively(SRC). However, volatilization from water surfaces is expected to be attenuated by adsorption to suspended solids and sediment in the water column. According to a classification scheme(5), an estimated BCF of 320(SRC), from an estimated log Kow of 4.31(2) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is high(SRC). Utilizing the Manometric Respirometry test, 93% of the Theoretical BOD was reached in 4 weeks indicating that biodegradation is an important environmental fate process in water(3). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), benzyl salicylate which has a vapor pressure of 7.8X10-5 mm Hg at 20 °C(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase benzyl salicylate is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 22 hours(SRC), calculated from its rate constant of 1.7X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase benzyl salicylate may be removed from the air by wet and dry deposition(SRC). Benzyl salicylate contains chromophores that absorb at wavelengths >290 nm(4) and, therefore, may be susceptible to direct photolysis by sunlight(SRC). Source: Hazardous Substances Data Bank (HSDB)

Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source

Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.

Couverture des sources complémentaires et état des correspondances
SourceRésultatVérifié
NIH PubChem PUG-ViewCorrespondance exacte2026-08-31

Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.

Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Recherche complémentaire sur la substance auprès de sources faisant autorité

Chaque lien lance une recherche de cette identité dans la source concernée. Un lien est une piste de recherche, et non l’affirmation que la source détient une fiche exacte. Ce qu’est chaque source et sa valeur juridique

Aller plus loin avec cette fiche

Analyser dans une formuleOuvrir la comparaison autonome

Source officielle et champ d’application

Importé de la décision d’exécution (UE) 2025/1175 de la Commission (version du jeu de données EU 2025/1175). Le glossaire fournit les dénominations communes des ingrédients pour la liste d’ingrédients exigée par l’article 19, paragraphe 1, point g) ; ce n’est ni une liste d’autorisation ni une liste de sécurité.

Ouvrir la décision officielle